Topic prioritisation
Showing 1 to 1 of 1
| Title | Prioritisation programme | Decision | Decision date |
|---|---|---|---|
| Crizotinib for treating ALK-positive anaplastic large cell lymphoma or inflammatory myofibroblastic tumour in people 6 to 17 years [TSID10574] | None selected | Not selected |